Brief: Cleo Diagnostics Commences U.S. Regulatory Process With FDA

CLEO Diagnostics

26/06/2024 02:27

June 26 (Reuters) - Cleo Diagnostics Ltd  COV.AX :
    * COMMENCES U.S. REGULATORY PROCESS WITH FDA
    * COMPLETED AN INITIAL PRE-SUBMISSION MEETING WITH FDA
    * OUTLINED ITS SUBMISSION FRAMEWORK AND CLINICAL PLAN FOR
ITS
OVARIAN CANCER DETECTION BLOOD TEST WITH FDA

Further company coverage:  COV.AX 

 ((Reuters.Briefs@thomsonreuters.com;))